Ultrasonic surgical aspirator in cytoreduction of splenic metastases to avoid splenectomy.
The Cavitron Ultrasonic Surgical Aspirator (Cavitron) was used to reduce the volume of splenic metastases in seven patients. Six patients had epithelial carcinoma of the ovary, and one had peritoneal mesothelioma. All patients had stage IIIC disease. Initially, six patients had malignant disease > 15 mm in diameter (of any single nodule), and one had disease 6-15 mm in diameter. In order to avoid resection of the spleen, cytoreduction could not be performed by standard means. After using the Cavitron, three patients had no gross residual disease, and four patients had disease 1-5 mm in diameter. No complication resulted from cytoreduction of splenic disease using the Cavitron, and splenectomy was not performed in any case. The Cavitron is invaluable in obtaining minimal residual disease of splenic metastases without performing splenectomy.
Adelson
M D
MD
Department of Obstetrics and Gynecology, State University of New York Health Science Center, Syracuse.
D000230:Adenocarcinoma / Q000556:secondary; D005260:Female; D006801:Humans; D008654:Mesothelioma / Q000556:secondary; D010051:Ovarian Neoplasms / Q000556:secondary; D010534:Peritoneal Neoplasms / Q000473:pathology; D011446:Prospective Studies; D013156:Splenectomy; D013160:Splenic Neoplasms / Q000556:secondary / Q000601:surgery*; D013396:Suction / Q000295:instrumentation / Q000379:methods*; D014464:Ultrasonic Therapy / Q000295:instrumentation